
The effects of GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in patients aged 9 to 15 years has indicated efficacy, according to a recent long-term follow-up study.

The effects of GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in patients aged 9 to 15 years has indicated efficacy, according to a recent long-term follow-up study.

In a recent study, improved neurodevelopmental outcomes were seen in children aged 2 years whose mothers received a Mediterranean diet or mindfulness-based stress reduction intervention during pregnancy.

In a recent study, long-term neurodevelopmental outcomes were improved in children of parents receiving pravastatin compared to placebo.

In a recent study, improved knowledge on preterm birth risks were seen in patients receiving a smartphone-based preterm birth education program.

In a recent study, no significant differences in math and reading test scores were found among children born at term with different gestational ages.

In a recent study, the prevalence of autism spectrum disorder was greater in children exposed to maternal labor epidural analgesia and oxytocin use during delivery.

Timothy Hand, PhD, associate professor of pediatrics and immunology at the University of Pittsburgh School of Medicine and UPMC Children’s Hospital of Pittsburgh, discusses how antibodies provided from breast milk can improve immunity in infants.

In a recent study, higher immunoglobulin G titers were seen in infants of mothers who received messenger RNA COVID-19 vaccination during pregnancy.

Norgestrel (Opill; HRA Pharma) is the first nonprescription oral contraceptive approved for use in the United States.

In a recent study, monozygotic twins with an increased birth rate had fewer autism traits and intellectual disability ratings.

Johnson & Johnson has announced positive safety and efficacy results in a phase 2 trial evaluating nipocalimab against early-onset severe hemolytic disease of the fetus and newborn.